Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Tuberculosis

Free Subscription Articles published in Eur J Clin Microbiol Infect Dis Retrieve available abstracts of 31 articles: HTML format

Single Articles

December 2025
1. QIU C, Zhou GF, Li GB, Ao J, et al
   Establishing a clinical tool to predict acute kidney injury in pulmonary tuberculosis: insights from a large-scale retrospective study.
   Eur J Clin Microbiol Infect Dis. 2025 Dec 30. doi: 10.1007/s10096-025-05382.
   PubMed    
   
   
   
2. ROTUNDO S, Serapide F, Guido G, Di Gennaro F, et al
   Is the unavailability of rifapentine holding back the end TB strategy in Europe? Implication for tuberculosis control among migrants and refugees.
   Eur J Clin Microbiol Infect Dis. 2025 Dec 16. doi: 10.1007/s10096-025-05304.
   PubMed    
   
   
   October 2025
3. KIM Y, Lee DG, Bae J, Jung J, et al
   Characteristic exploration of Mycobacterium tuberculosis isolated from patients with linezolid-treated multidrug-resistant tuberculosis.
   Eur J Clin Microbiol Infect Dis. 2025 Oct 29. doi: 10.1007/s10096-025-05319.
   PubMed     Abstract available
   
   
   
4. ROTUNDO S, Serapide F, d'Ettorre G, Tassone MT, et al
   Managing tuberculosis infection among migrants from high-incidence tuberculosis countries: challenges, strategies and recommendations.
   Eur J Clin Microbiol Infect Dis. 2025 Oct 9. doi: 10.1007/s10096-025-05301.
   PubMed     Abstract available
   
   
   July 2025
5. JAIN B, Kulkarni S, Baghel NS
   Rapid screening of mutations for second-line-drug-resistant genes in Mycobacterium tuberculosis culture isolates by in-house developed DNA bio-chip.
   Eur J Clin Microbiol Infect Dis. 2025 Jul 29. doi: 10.1007/s10096-025-05221.
   PubMed     Abstract available
   
   
   
6. YIGCI D, Kayi I, Demiroglu YZ, Kutlu M, et al
   Tuberculosis in Turkiye: Epidemiological insights and recommendations for progress.
   Eur J Clin Microbiol Infect Dis. 2025 Jul 15. doi: 10.1007/s10096-025-05201.
   PubMed     Abstract available
   
   
   
7. GUO S, Zhang Z, Perez AA, Xianyu F, et al
   Effectiveness of centralized hospitalization treatment on transmission in household contacts of pulmonary tuberculosis patients: a contact-traced study.
   Eur J Clin Microbiol Infect Dis. 2025 Jul 3. doi: 10.1007/s10096-025-05170.
   PubMed     Abstract available
   
   
   
8. CARVALHO BT, Meirinhos SV, Domingos GJ, Peixoto S, et al
   Unseen but unforgettable - refractive bacilli in the gram stain of a muscular abscess.
   Eur J Clin Microbiol Infect Dis. 2025;44:1749-1752.
   PubMed     Abstract available
   
   
   May 2025
9. MALHOTRA AG, Lokhande L, Pakhare A, Soni P, et al
   Diagnostic yield of Xpert MTB/RIF, Xpert MTB/RIF Ultra, and Truenat MTB assays on non-pulmonary samples from suspected cases of extra-pulmonary tuberculosis (EPTB).
   Eur J Clin Microbiol Infect Dis. 2025 May 31. doi: 10.1007/s10096-025-05177.
   PubMed     Abstract available
   
   
   
10. FEI ZT, Zhou DP, Huang W, Liu P, et al
    Clinical characteristics and outcomes of tuberculosis and non-tuberculous mycobacteria infections: a population-based study of concurrent and sequential infections.
    Eur J Clin Microbiol Infect Dis. 2025 May 9. doi: 10.1007/s10096-025-05151.
    PubMed     Abstract available
    
    
    April 2025
11. DING W, Shen L, Li R, Yang X, et al
    Treatment of pre-extensively drug-resistant tuberculosis in a 4-month-old infant using a regimen of bedaquiline, delamanid, and contezolid.
    Eur J Clin Microbiol Infect Dis. 2025 Apr 9. doi: 10.1007/s10096-025-05128.
    PubMed     Abstract available
    
    
    March 2025
12. QUAN DH, Wang T, Martinez E, Kim HY, et al
    Beta-lactam combination treatment overcomes rifampicin resistance in Mycobacterium tuberculosis.
    Eur J Clin Microbiol Infect Dis. 2025 Mar 6. doi: 10.1007/s10096-025-05062.
    PubMed     Abstract available
    
    
    January 2025
13. WANG MQ, Zheng YF, Hu YQ, Huang JX, et al
    Diagnostic accuracy of Xpert MTB/RIF Ultra for detecting pulmonary tuberculosis and rifampicin resistance: a systematic review and meta-analysis.
    Eur J Clin Microbiol Infect Dis. 2025 Jan 4. doi: 10.1007/s10096-024-05032.
    PubMed     Abstract available
    
    
    August 2024
14. TURAN H, Gunak F, Yasaci Z, Ethemoglu G, et al
    Impact of the COVID-19 pandemic and migration on tuberculosis notifications: a retrospective analysis with 5-year data from three centers.
    Eur J Clin Microbiol Infect Dis. 2024 Aug 7. doi: 10.1007/s10096-024-04918.
    PubMed     Abstract available
    
    
    
15. ZHANG W, Xu J, Zhang L, Ni T, et al
    The value of histopathologic examination and Xpert (MTB/RIF) assay in diagnosis of cervical lymph node tuberculosis after coarse needle biopsy guided by CEUS: a retrospective analysis of 612 cases.
    Eur J Clin Microbiol Infect Dis. 2024 Aug 1. doi: 10.1007/s10096-024-04913.
    PubMed     Abstract available
    
    
    July 2024
16. FERRER J, Gimenez E, Carretero D, Clari MA, et al
    Abbott realtime MTB assay for detecting Mycobacterium tuberculosis complex in respiratory specimens: a cost-benefit analysis.
    Eur J Clin Microbiol Infect Dis. 2024 Jul 3. doi: 10.1007/s10096-024-04880.
    PubMed     Abstract available
    
    
    June 2024
17. WEN R, Xiao J, Ding N, Zhong Y, et al
    Suitability of reduced dose glucocorticoids therapy regimen for antibody-associated vasculitis patients with TB: a retrospective study.
    Eur J Clin Microbiol Infect Dis. 2024;43:1061-1072.
    PubMed     Abstract available
    
    
    April 2024
18. CHEN Y, Liu J, Zhang Q, Chen H, et al
    Global burden of MDR-TB and XDR-TB attributable to high fasting plasma glucose from 1990 to 2019: a retrospective analysis based on the global burden of disease study 2019.
    Eur J Clin Microbiol Infect Dis. 2024;43:747-765.
    PubMed     Abstract available
    
    
    February 2024
19. CAO X, Guo T, Xin H, Du J, et al
    Cost-effectiveness of latent tuberculosis infection testing and treatment with 6-week regimen among key population in rural communities in China: a decision analysis study.
    Eur J Clin Microbiol Infect Dis. 2024 Feb 22. doi: 10.1007/s10096-024-04777.
    PubMed     Abstract available
    
    
    January 2024
20. ACHEAMPONG I, Minadzi D, Laing EF, Frimpong M, et al
    Differences in PPD- and mitogen-induced T-cell activation marker expression characterize immunopathology in acute tuberculosis patients.
    Eur J Clin Microbiol Infect Dis. 2024 Jan 3. doi: 10.1007/s10096-023-04741.
    PubMed     Abstract available
    
    
    December 2023
21. SUN H, Ma Z, Ai F, Han B, et al
    Insidious transmission of Mycobacterium tuberculosis in Ordos, China: a molecular epidemiology study.
    Eur J Clin Microbiol Infect Dis. 2023 Dec 6. doi: 10.1007/s10096-023-04730.
    PubMed     Abstract available
    
    
    
22. QUAN Z, Li M, Chen Y, Liang J, et al
    Performance evaluation of core genome multilocus sequence typing for genotyping of Mycobacterium tuberculosis strains in China: based on multicenter, population-based collection.
    Eur J Clin Microbiol Infect Dis. 2023 Dec 2. doi: 10.1007/s10096-023-04720.
    PubMed     Abstract available
    
    
    November 2023
23. OU X, Song Z, Zhao B, Pei S, et al
    Diagnostic efficacy of an optimized nucleotide MALDI-TOF-MS assay for anti-tuberculosis drug resistance detection.
    Eur J Clin Microbiol Infect Dis. 2023 Nov 18. doi: 10.1007/s10096-023-04700.
    PubMed     Abstract available
    
    
    
24. PINHATA JMW, Ferrazoli L, Mendes FF, Goncalves MG, et al
    A descriptive study on isoniazid resistance-associated mutations, clustering and treatment outcomes of drug-resistant tuberculosis in a high burden country.
    Eur J Clin Microbiol Infect Dis. 2023 Nov 9. doi: 10.1007/s10096-023-04693.
    PubMed     Abstract available
    
    
    September 2023
25. NAGDEV PK, Agnivesh PK, Roy A, Sau S, et al
    Exploring and exploiting the host cell autophagy during Mycobacterium tuberculosis infection.
    Eur J Clin Microbiol Infect Dis. 2023 Sep 23. doi: 10.1007/s10096-023-04663.
    PubMed     Abstract available
    
    
    July 2023
26. MEI ZX, Han JF, Yu HW, Zhang Y, et al
    Detection of serum Aspergillus-specific IgM and IgG antibody levels for the diagnosis of chronic pulmonary aspergillosis developed in patients with tuberculosis.
    Eur J Clin Microbiol Infect Dis. 2023 Jul 16. doi: 10.1007/s10096-023-04637.
    PubMed     Abstract available
    
    
    June 2023
27. TANOGLU A, Erdem H, Friedland JS, Ankarali H, et al
    Clinicopathological profile of peritoneal tuberculosis and a new scoring model for predicting mortality: an international ID-IRI study.
    Eur J Clin Microbiol Infect Dis. 2023 Jun 15. doi: 10.1007/s10096-023-04630.
    PubMed     Abstract available
    
    
    May 2023
28. LIU Y, Ren W, Xue Z, Miao Y, et al
    Real-time recombinase-aided amplification assay for rapid amplification of the IS1081 gene of Mycobacterium tuberculosis.
    Eur J Clin Microbiol Infect Dis. 2023 May 31. doi: 10.1007/s10096-023-04626.
    PubMed     Abstract available
    
    
    
29. CASTRO-LIMA VAC, Santos APT, Musqueira PT, Maluf NZ, et al
    Prevalence of latent Mycobacterium tuberculosis infection in hematopoietic stem cell transplantation comparing tuberculin skin test and interferon-gamma release assay.
    Eur J Clin Microbiol Infect Dis. 2023 May 1. doi: 10.1007/s10096-023-04613.
    PubMed     Abstract available
    
    
    April 2023
30. YEZLI S, Yassin Y, Mushi A, Maashi F, et al
    Undiagnosed and missed active pulmonary tuberculosis during mass gatherings: a prospective cross-sectional study from the Hajj pilgrimage.
    Eur J Clin Microbiol Infect Dis. 2023.
    PubMed     Abstract available
    
    
    February 2023
31. YANG L, Xiang F, Wang D, Guo Q, et al
    The safety and immunogenicity of inactivated COVID-19 vaccine in old pulmonary tuberculosis patients.
    Eur J Clin Microbiol Infect Dis. 2023.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Tuberculosis is free of charge.